Hepatitis D epidemiology and demographics

Jump to navigation Jump to search

Hepatitis Main Page

Hepatitis D

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis D epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis D epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis D epidemiology and demographics

CDC on Hepatitis D epidemiology and demographics

Hepatitis D epidemiology and demographics in the news

Blogs on Hepatitis D epidemiology and demographics

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]

Overview

HDV is rare in most developed countries, and is mostly associated with intravenous drug abuse. However HDV is much more common in Mediterranean countries, sub-Saharan Africa, the Middle East, and countries in the northern part of South America.[1] In all, about 20 million people may be infected with HDV.[2]

Epidemiology and Demographics

Prevalence

Worldwide, more than 15 million people have evidence of serological exposure to HDV worldwide. Areas of high endemicity include Central Africa, the Horn of Africa, the Middle East, eastern and Mediterranean Europe, the Amazon Basin, and parts of Asia. HDV infection rates usually correlate with HBV endemicity except in countries such as Indonesia and Vietnam, where co-infection is uncommon. Prevalence of HDV infection ranges between provinces in China, a country with high endemicity of HBV. [3] Two epidemiological patterns of hepatitis D infection exist: in Western Europe and North America, HDV is limited to persons exposed to blood or blood products such as with intravenous drug use. In Mediterranean countries, HDV infection is endemic among HBV carriers. In this population, the virus is transmitted by close personal contact. [4]

New foci of high HDV prevalence continue to be identified including areas of China, Northern India, Albania, and Okinawa, Japan. [4]

HDV prevalence is decreasing in many areas of the world including Spain, Turkey, and Taiwan, especially in the last three decades. This has been attributed to vaccination programs for HBV, increased awareness, and an overall improvement in socioeconomic conditions. [3] It should be noted that data for HBV prevalence in developing countries is sparse.

Adapted from Center for Disease Control and Prevention(CDC)[5]

Incidence

Developed Countries

HDV infection remains prevalent in France. In Germany and the UK, the prevalence of HDV has increased.

References

  1. Radjef N, Gordien E, Ivaniushina V; et al. (2004). "Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades". J. Virol. 78 (5): 2537–44. doi:10.1128/JVI.78.5.2537-2544.2004. PMC 369207. PMID 14963156. Unknown parameter |month= ignored (help)
  2. Taylor JM (2006). "Hepatitis delta virus". Virology. 344 (1): 71–6. doi:10.1016/j.virol.2005.09.033. PMID 16364738. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Hughes SA, Wedemeyer H, Harrison PM (2011). "Hepatitis delta virus". Lancet. 378 (9785): 73–85. doi:10.1016/S0140-6736(10)61931-9. PMID 21511329.
  4. 4.0 4.1 World Health Organization. Department of Communicable Disease Surveillance and Response.http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf?ua=1
  5. "Center for Disease Control and Prevention (CDC)".

Template:WH Template:WS